These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11980673)

  • 1. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo.
    Ji L; Nishizaki M; Gao B; Burbee D; Kondo M; Kamibayashi C; Xu K; Yen N; Atkinson EN; Fang B; Lerman MI; Roth JA; Minna JD
    Cancer Res; 2002 May; 62(9):2715-20. PubMed ID: 11980673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.
    Chow LS; Lo KW; Kwong J; To KF; Tsang KS; Lam CW; Dammann R; Huang DP
    Int J Cancer; 2004 May; 109(6):839-47. PubMed ID: 15027117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo.
    Ito I; Ji L; Tanaka F; Saito Y; Gopalan B; Branch CD; Xu K; Atkinson EN; Bekele BN; Stephens LC; Minna JD; Roth JA; Ramesh R
    Cancer Gene Ther; 2004 Nov; 11(11):733-9. PubMed ID: 15486560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].
    Anedchenko EA; Dmitriev AA; Krasnov GS; Kondrat'eva TT; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Zborovskaia IB; Polotskiĭ BE; Sakharova OV; Kashuba VI; Zabarovskiĭ ER; Senchenko VN
    Mol Biol (Mosk); 2008; 42(6):965-76. PubMed ID: 19140316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy.
    Ohtani S; Iwamaru A; Deng W; Ueda K; Wu G; Jayachandran G; Kondo S; Atkinson EN; Minna JD; Roth JA; Ji L
    Cancer Res; 2007 Jul; 67(13):6293-303. PubMed ID: 17616688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3.
    Oh JJ; West AR; Fishbein MC; Slamon DJ
    Cancer Res; 2002 Jun; 62(11):3207-13. PubMed ID: 12036935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the 3p21.3 tumour-suppressor gene cluster.
    Hesson LB; Cooper WN; Latif F
    Oncogene; 2007 Nov; 26(52):7283-301. PubMed ID: 17533367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells.
    Kondo M; Ji L; Kamibayashi C; Tomizawa Y; Randle D; Sekido Y; Yokota J; Kashuba V; Zabarovsky E; Kuzmin I; Lerman M; Roth J; Minna JD
    Oncogene; 2001 Sep; 20(43):6258-62. PubMed ID: 11593436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
    Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
    Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells.
    Ueda K; Kawashima H; Ohtani S; Deng WG; Ravoori M; Bankson J; Gao B; Girard L; Minna JD; Roth JA; Kundra V; Ji L
    Cancer Res; 2006 Oct; 66(19):9682-90. PubMed ID: 17018626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells.
    Deng WG; Kawashima H; Wu G; Jayachandran G; Xu K; Minna JD; Roth JA; Ji L
    Cancer Res; 2007 Jan; 67(2):709-17. PubMed ID: 17234782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
    Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of antitumor activity of cisplatin in human lung cancer cells by tumor suppressor FUS1.
    Deng WG; Wu G; Ueda K; Xu K; Roth JA; Ji L
    Cancer Gene Ther; 2008 Jan; 15(1):29-39. PubMed ID: 17828283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
    Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
    Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The two single nucleotide polymorphisms in the H37/RBM5 tumour suppressor gene at 3p21.3 correlated with different subtypes of non-small cell lung cancers.
    Oh JJ; Koegel AK; Phan DT; Razfar A; Slamon DJ
    Lung Cancer; 2007 Oct; 58(1):7-14. PubMed ID: 17606309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis.
    Oh JJ; Razfar A; Delgado I; Reed RA; Malkina A; Boctor B; Slamon DJ
    Cancer Res; 2006 Apr; 66(7):3419-27. PubMed ID: 16585163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity.
    Carboni GL; Gao B; Nishizaki M; Xu K; Minna JD; Roth JA; Ji L
    Oncogene; 2003 Jan; 22(4):615-26. PubMed ID: 12555074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C.
    Li J; Wang F; Haraldson K; Protopopov A; Duh FM; Geil L; Kuzmin I; Minna JD; Stanbridge E; Braga E; Kashuba VI; Klein G; Lerman MI; Zabarovsky ER
    Cancer Res; 2004 Sep; 64(18):6438-43. PubMed ID: 15374952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo.
    Todd MC; Xiang RH; Garcia DK; Kerbacher KE; Moore SL; Hensel CH; Liu P; Siciliano MJ; Kok K; van den Berg A; Veldhuis P; Buys CH; Killary AM; Naylor SL
    Oncogene; 1996 Dec; 13(11):2387-96. PubMed ID: 8957080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.